You are here

Evaluation of an Online, Remote Cognitive Battery for use in Cancer Survivorship

Workflow State: 
Recruitment Requested
Type of proposal: 
Participant recruitment (what is this?)
Does this project have funding?: 
Yes

Researcher Information

First name: 
James
Last name: 
Root
Degree: 
PhD
Work phone number: 
(646) 888-0035

Institution Information

Memorial Sloan Kettering Cancer Center
641 Lexington Avenue
11102 New York , NY
United States

Project Information

List of Collaborators: 
Duane Jung, B.S., Enformia
Number of Participants Needed: 
140
Inclusion and Exclusion Criteria: 
*Please note: For this research study, our team is requesting to recruit only healthy controls (no breast cancer survivors) using Army of Women. Inclusion Criteria: 1. Female 2. Age 40-65 at time of assessment 3. Score of < 11 on the Blessed Orientation-Memory-Concentration Test (BOMC) 4. If currently taking psychoactive medications (including but not limited to antidepressants, and anxiolytics), dose must have been stable for at least two months prior to enrollment by subject report. 5. English fluent (as per self-reported fluency of "very well") 6. As per self-report, no history of cancer except non-melanoma/ basal cell skin cancer/ squamous cell skin carcinoma Exclusion Criteria: 1. Diagnosis of neurodegenerative disorder that affects cognitive function (e.g. Alzheimer‟s disease, Parkinson‟s disease, Multiple Sclerosis, Dementia, Seizure Disorders, etc.) 2. As per medical record or self-report, history of stroke or head injury requiring visit to the emergency room or hospitalization 3. By self-report, fine motor/motor impairments that interfere with participant’s ability to use a keyboard. 4. As per self-report, a diagnosis of a Schizophrenia Spectrum Disorder, substance use disorder, Bipolar Disorder or Schizotypal personality disorder. Schizophrenia Spectrum Disorders include Schizophrenia, Schizophreniform disorder, Schizoaffective disorder, Delusional disorder, Brief psychotic disorder, and Attenuated Psychotic Disorder. 5. Visual or auditory impairment that would preclude ability to complete the assessments (e.g. history of significant macular degeneration or being unable to correct hearing with hearing aids) 6. Use of methotrexate (Amethopterin, Rhematrex, Trexall) or rituximab (Rituxan) for rheumatoid arthritis, psoriasis or Crohn‟s disease, or cyclophosphamide (Cytoxan, Neosar) for Lupus.
NIH Biosketch: 
Scientific Abstract: 

Project Details

Primary Area of Study: 
Budget Award Letter: 
Complete Grant Application (protocol if not grant-funded): 
IRB Approval: 
Yes
IRB Approval Document: